Influenza A Virus, H1N1 Subtype
"Influenza A Virus, H1N1 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of INFLUENZA A VIRUS with the surface proteins hemagglutinin 1 and neuraminidase 1. The H1N1 subtype was responsible for the Spanish flu pandemic of 1918.
Descriptor ID |
D053118
|
MeSH Number(s) |
B04.820.545.405.400.214
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Influenza A Virus, H1N1 Subtype".
Below are MeSH descriptors whose meaning is more specific than "Influenza A Virus, H1N1 Subtype".
This graph shows the total number of publications written about "Influenza A Virus, H1N1 Subtype" by people in this website by year, and whether "Influenza A Virus, H1N1 Subtype" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 1 | 0 | 1 |
2009 | 2 | 1 | 3 |
2011 | 3 | 0 | 3 |
2012 | 4 | 0 | 4 |
2013 | 0 | 2 | 2 |
2014 | 1 | 2 | 3 |
2015 | 0 | 2 | 2 |
2016 | 1 | 1 | 2 |
2018 | 2 | 1 | 3 |
2019 | 2 | 1 | 3 |
2020 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza A Virus, H1N1 Subtype" by people in Profiles.
-
Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa. Vaccine. 2020 09 22; 38(41):6478-6483.
-
Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness. Clin Infect Dis. 2020 08 14; 71(4):1072-1079.
-
Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveill. 2019 Nov; 24(45).
-
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLoS One. 2019; 14(9):e0222381.
-
Live attenuated influenza vaccines for African children. Lancet Respir Med. 2019 08; 7(8):641-643.
-
Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine. 2019 03 22; 37(13):1876-1884.
-
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa. Influenza Other Respir Viruses. 2019 01; 13(1):54-63.
-
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. BMC Infect Dis. 2018 06 08; 18(1):269.
-
Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
-
The Effects of Influenza Vaccination during Pregnancy on Birth Outcomes: A Systematic Review and Meta-Analysis. Am J Perinatol. 2016 09; 33(11):1104-14.